A Mayo Clinic study suggests postmenopausal women lost 35% more weight combining hormone therapy with tirzepatide, though ...

A combination of hormone therapy and the GLP-1 drug tirzepatide may promote weight loss in postmenopausal females. Image Credit: Mauro Grigollo/Stocksy Menopause can accelerate age-related weight gain ...

Postmenopausal women may have a powerful new edge in the battle against weight gain. A Mayo Clinic study found that those using menopausal hormone therapy while taking the obesity drug tirzepatide ...

JACKSONVILLE, Fla. — A new study led by Mayo Clinic found that postmenopausal women receiving menopausal hormone therapy lost 35% more weight while taking tirzepatide, a Food and Drug ...

· Weight gain is a common side effect of menopause. · Scientists found that women who took hormone therapy and the weight loss drug tirzepatide lost more weight than those who took tirzepatide alone. ...

SAN FRANCISCO—Using tirzepatide and menopause hormone therapy at the same time leads to increased weight loss in postmenopausal women with overweight or obesity compared to use of tirzepatide ...

(Halfpoint Images/Moment/Getty Images) Scientists have uncovered a potential drug combo that may supercharge popular ...

The advertiser paid a fee to promote this sponsored article and may have influenced or authored the content. The views expressed in this article are those of the advertiser and do not necessarily ...

Please provide your email address to receive an email when new articles are posted on . “We found an association between hormone therapy use and greater weight loss in postmenopausal women,” Regina ...

Share on Pinterest For some females experiencing menopause weight gain, dietary changes may not be enough on their own. Getty Images/Cultura Creative More women are seeking solutions to manage ...

A new study found that postmenopausal females who use hormone therapy in combination with tirzepatide experience greater weight loss compared to those who don’t. Tirzepatide (Zepbound) is an ...